Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 03, 2013 09:00 ET | Source: Crescendo Bioscience

Crescendo Bioscience(R) Secures $28 Million in Series D Financing

SOUTH SAN FRANCISCO, Calif., Jan. 3, 2013 (GLOBE NEWSWIRE) -- Crescendo Bioscience®, a molecular diagnostics company dedicated to developing and commercializing quantitative blood tests for...
November 10, 2012 16:30 ET | Source: Crescendo Bioscience

Crescendo Bioscience to Present Data on the Use of Vectra(TM) DA in Assessing Response to Treatments at American College of Rheumatology/Associate Rheumatology Health Professional Annual Meeting

SOUTH SAN FRANCISCO, Calif., Nov. 10, 2012 (GLOBE NEWSWIRE) -- Crescendo Bioscience®, a molecular diagnostics company dedicated to developing and commercializing quantitative blood tests for...
June 13, 2012 10:00 ET | Source: Crescendo Bioscience

Crescendo Bioscience(R) Names Industry Leader Oscar Segurado, M.D., Ph.D., Chief Medical Officer

SOUTH SAN FRANCISCO, Calif., June 13, 2012 (GLOBE NEWSWIRE) -- Crescendo Bioscience®, a molecular diagnostics company developing and commercializing quantitative, biology-based tests for...
May 17, 2012 13:40 ET | Source: Crescendo Bioscience

Nidus Announces Crescendo Bioscience is First Corporate Sponsor

SPOKANE, Wash., May 17, 2012 (GLOBE NEWSWIRE) -- The Nidus Physician Network Care Organization, a national medical organization dedicated to building partnerships between community and academic...
September 08, 2011 16:15 ET | Source: Crescendo Bioscience

Crescendo Bioscience(R) Secures $56 Million in Funding to Expand Development and Commercialization of Personalized Diagnostics for Inflammatory Diseases

SOUTH SAN FRANCISCO, Calif., Sept. 8, 2011 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a molecular diagnostics company developing quantitative biomarker tests for rheumatoid arthritis (RA) and other...